HCW Biologics Inc. (HCWB)

AI Score

Unlock

7.92

-0.01 (-0.13%)

At close: Apr 24, 2025, 3:59 PM

7.94

0.25%

After-hours: Apr 24, 2025, 04:00 PM EDT

HCW Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-3.37M	-3.9M	-15.28M	-7.47M	-10.68M	-4.94M	-4.3M	-5.07M	-5.42M	-3.91M	-3.51M	-2.06M	-3.17M	-4.09M	-2.75M	-2.84M	2.06M	-2.71M	-2.78M	-2.38M
Depreciation & Amortization	682.51K	128.45K	129.93K	243.5K	274.55K	277.45K	284.33K	298.85K	261.16K	164.33K	149.58K	142.78K	95.58K	124.12K	165.09K	158.81K	163.69K	126.21K	158.11K	147.9K
Stock-Based Compensation	292.07K	232.43K	239.82K	244.69K	261.27K	219.85K	263.42K	259.21K	286.19K	302.32K	271.33K	260.35K	360.98K	1.66K	n/a	n/a	21.88K	n/a	n/a	n/a
Other Working Capital	2.58K	125.24K	401.17K	246.1K	599.67K	-283.69K	-5.56M	103.07K	589.53K	-48.17K	445.54K	1.37M	-2.5M	41.16M	5.88M	-150.36K	-2.14M	-195.49K	26.83K	188.25K
Other Non-Cash Items	n/a	n/a	n/a	-2.4M	5.66M	-627	-627	-112.29K	-66.55K	627.00	24.84K	185.33K	1.46M	-221.53K	-1.68M	-567.31K	21.88K	28.74K	430.36K	57.92K
Deferred Income Tax	n/a	n/a	n/a	n/a	-409.5K	-40.63K	-110.94K	n/a	n/a	n/a	n/a	n/a	-1.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-436.19K	614.93K	10.05M	3.38M	1M	-1.11M	-5.52M	986.71K	1.15M	1.09M	374.97K	-123.42K	-753.84K	-1.15M	1.59M	1.76M	-5.78M	-166.74K	457.19K	246.16K
Operating Cash Flow	-2.83M	-2.93M	-4.86M	-3.6M	-3.89M	-5.59M	-9.39M	-3.64M	-3.79M	-2.31M	-2.69M	-1.59M	-3.38M	-5.12M	-990.44K	-1.49M	-3.54M	-2.75M	-2.16M	-1.98M
Capital Expenditures	-113.41K	-37.06K	18.57K	-129.71K	-3.72M	-630.05K	-1.56M	-300.38K	-68.69K	-10.17M	-12.91K	-23.55K	-19.85K	-4.13K	n/a	-23.28K	-36.39K	-105.22K	55.78K	-100.86K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4.05K	-34.97M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	10M	n/a	n/a	8M	16.98M	n/a	8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	10M	n/a	n/a	-8M	16.98M	n/a	8M	-4.05K	-34.97M	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-113.41K	-37.06K	18.57K	-129.71K	-3.72M	9.37M	-1.56M	-300.38K	-68.69K	6.81M	-12.91K	7.98M	-23.9K	-34.97M	n/a	-23.28K	-36.39K	-105.22K	55.78K	-100.86K
Debt Repayment	343.99K	2.8M	1.92M	1.72M	-29.29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.32M	n/a	n/a	2.5M	n/a	-8.98K	n/a	n/a	-45.68K	6.3M	n/a	n/a	n/a	-5.84M	-824.31K	-100K	563.59K	6.17M	n/a	n/a
Financial Cash Flow	6.62M	2.8M	1.92M	4.22M	-15.25K	-8.9K	7.71K	1.9K	-39.85K	6.3M	6K	2.27K	6.1K	50.16M	-814.85K	-86.61K	5.55M	6.17M	2.31K	n/a
Net Cash Flow	3.68M	-163.09K	-2.92M	488.97K	-7.63M	3.77M	-10.94M	-3.94M	-3.9M	10.8M	-2.7M	6.39M	-3.39M	10.07M	-1.81M	-1.6M	1.97M	3.31M	-2.11M	-2.08M
Free Cash Flow	-2.95M	-2.96M	-4.84M	-3.73M	-7.61M	-6.22M	-10.95M	-3.94M	-3.86M	-12.48M	-2.7M	-1.62M	-3.4M	-5.12M	-990.44K	-1.51M	-3.57M	-2.85M	-2.11M	-2.08M